Fund BasicsSee More
- Fund Family Invesco
- Assets Under Management 784,659,600
- Market Capitalization, $K 784,660
- Shares Outstanding, K 14,220
- 60-Month Beta 1.55
|Period||Period Low||Period High||Performance|
| || |
+12.30 (+28.83%)since 10/27/20
| || |
+11.13 (+25.39%)since 08/27/20
| || |
+10.32 (+23.11%)since 11/27/19
After almost a year-long wait, the month of November started delivering sweet surprises to investors in the form of back-to-back vaccine news.
The momentum was driven by a vaccine development, which is being viewed as "a beginning to the end" of the coronavirus pandemic, and the prospect of divided congress, which is considered favorable for...
Wall Street soared on Nov 9 on news that Pfizer (PFE) and BioNTech (BNTX) vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial.
Wall Street has regained momentum this week hitting new highs on vaccine hopes.
I think of SPHB as the ETF to own if you think everything will eventually turn out well According to people who follow such things, the ancient Mayan calendar predicted that world was going to end...
While every corner of the market is enjoying this ascent, high-beta ETFs and stocks seem a perfect bet at present.
This high beta ETF hits a new 52-week high. Are more gains in store for this ETF?
Solid jobs data for the month of May, reopening of global economies, further stimulus announcement from the ECB, signs of recovery in the U.S. manufacturing activity ??? all led to the market rally last...
As the U.S. economy reopens, Wall Street may remain charged up, benefiting high-beta ETFs. Investors can tap those with cheaper valuation.
Trade deal optimism coupled with the Santa Claus rally have turned the market super bullish for the last five trading days left this year.